In The News Posted January 9, 2020 Share Posted January 9, 2020 SILVER SPRING, Md., Jan. 9, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ayvakit (avapritinib) for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body)... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.